RESEARCHER PROFILE

David E. Koren

← Back to Temple University Health System

D

Temple University Health System

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV Research and TreatmentPharmacy and Medical PracticesHepatitis C virus research

David E. Koren works in HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment, Pharmacy and Medical Practices, Hepatitis C virus research. Recorded institutional associations include Temple University Hospital, Temple University Health System.

38Publications
602Citations
13H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019

    2020 · 214 citations
  2. HIV Pre-Exposure Prophylaxis and Women: Survey of the Knowledge, Attitudes, and Beliefs in an Urban Obstetrics/Gynecology Clinic

    2018 · 66 citations
  3. The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis

    2019 · 58 citations
  4. Expanding Hepatitis C Virus Care and Cure: National Experience Using a Clinical Pharmacist–Driven Model

    2019 · 34 citations
  5. A Call to Action: The Role of Antiretroviral Stewardship in Inpatient Practice, a Joint Policy Paper of the Infectious Diseases Society of America, HIV Medicine Association, and American Academy of HIV Medicine

    2019 · 34 citations
  6. HIV: how to manage heavily treatment-experienced patients

    2022 · 24 citations
  7. Lenacapavir: A Novel Long-Acting Capsid Inhibitor for HIV

    2023 · 23 citations
  8. Ibalizumab

    2018 · 22 citations
  9. Impact of an Antiretroviral Stewardship Team on the Care of Patients With Human Immunodeficiency Virus Infection Admitted to an Academic Medical Center

    2019 · 20 citations
  10. Fostemsavir: A Novel Attachment Inhibitor for Patients With Multidrug-Resistant HIV-1 Infection

    2020 · 18 citations
  11. Hepatitis C Update and Expanding the Role of Primary Care

    2019 · 17 citations
  12. Perceptions of Long-Acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center

    2020 · 16 citations
  13. Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV ‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists

    2024 · 14 citations
  14. Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy

    2020 · 11 citations
  15. Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary

    2024 · 9 citations
  16. Crushing and Splitting Direct-Acting Antivirals for Hepatitis C Virus Treatment: A Case Series and Literature Review

    2021 · 8 citations
  17. Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series

    2022 · 5 citations
  18. 2498. Perceptions of Injectable Antiretrovirals in an Urban HIV Clinic

    2019 · 3 citations
  19. Implementation Determinants of HIV Testing and Pre-Exposure Prophylaxis in Community Pharmacies in Philadelphia, PA

    2025 · 2 citations
  20. Lenacapavir: A Twice-Yearly Injectable for HIV Preexposure Prophylaxis

    2025 · 2 citations
  21. Classes of Antiretrovirals

    2019 · 1 citations
  22. Physician Survey Results: Clinical Practice Training Is Needed to Improve Ob/Gyn PrEP Adoption [02A]

    2020 · 1 citations
  23. 1040. Real-World Implementation of Dolutegravir-Lamivudine to Achieve and Maintain HIV-1 Viral Suppression at an Academic Medical Center

    2020 · 1 citations
  24. 592. Determining the Impact of an Antiretroviral Stewardship Team on the Care of HIV-Infected Patients Admitted to an Academic Research Institution

    2018 · 0 citations
  25. PIN93 PREDICTION MODEL OF TREATMENT FAILURE AMONG CHRONIC HEPATITIS C PATIENTS AT FOUR UNITED STATES INSTITUTIONS

    2019 · 0 citations

← Return to the university profile